Results 11 to 20 of about 22,136 (209)
Escitalopram-Induced Hyperprolactinemic Galactorrhea
Amrita Journal of Medicine, 2022 Galactorrhea is milky secretions from the breast in women who have not breast-fed for a year. Escitalopram, a selective serotonin reuptake inhibitor (SSRI), owing to its potency and tolerance, is regarded as the primary line drug in the management of ...
Deepthi Yedla, Vijayan Sharmila
doaj +2 more sources
Patient Preference and Adherence, 2012 Eiji Kirino1,21Department of Psychiatry, Juntendo University Shizuoka Hospital, Shizuoka, Japan; 2Department of Psychiatry, Juntendo University School of Medicine, Tokyo, JapanAbstract: Escitalopram (escitalopram oxalate; Cipralex®, Lexapro& ...
Kirino E
doaj +1 more source
Bilateral Acute Angle-Closure Glaucoma Induced By Escitalopram
Türk Oftalmoloji Dergisi, 2014 Escitalopram is an antidepressant of the selective serotonin reuptake inhibitor(SSRI) class. In this manuscript, we report the case of a female patient who developed bilateral acute angle-closure glaucoma induced by escitalopram.
Dilbade Yıldız Ekinci +3 more
doaj +2 more sources
Case Reports in Nephrology, 2018 Hyponatremia is a well-known medication related side effect of selective serotonin reuptake inhibitors; despite its association with escitalopram, the newest SSRI is very rare.
Rishi Raj +4 more
doaj +2 more sources
Dosage-related nature of escitalopram treatment-emergent mania/hypomania: a case series
Neuropsychiatric Disease and Treatment, 2018 Yasunari Yamaguchi, Sohei Kimoto, Takeshi Nagahama, Toshifumi Kishimoto Department of Psychiatry, Nara Medical University School of Medicine, Kashihara, Japan Objective: Several studies have documented that treatment with various antidepressant agents ...
Yamaguchi Y +3 more
doaj +1 more source
Reprocessing Mass Spectra from Therapeutic Drug Monitoring to Unveil Proton Pump Inhibitor Use and Quantify Phenoconversion of Escitalopram Metabolism in CYP2C19-Genotyped Patients. [PDF]
Clin Pharmacol TherEscitalopram is a frequently prescribed antidepressant drug. CYP2C19 genotype is a major determinant of escitalopram metabolism and treatment outcome. However, real‐life studies show a high degree of genotype–phenotype mismatch in escitalopram metabolism.
Hole K +3 more
europepmc +2 more sources
Comparative efficacy of escitalopram in the treatment of major depressive disorder [PDF]
Neuropsychiatric Disease and Treatment, 2011 Mazen K Ali, Raymond W LamDepartment of Psychiatry, University of British Columbia, and Mood Disorders Centre, University of British Columbia Hospital, Vancouver, CanadaBackground: Escitalopram is an allosteric selective serotonin reuptake inhibitor ...
Mazen K Ali, Raymond W Lam
doaj +2 more sources
Safety of escitalopram in pregnancy: a case series [PDF]
Neuropsychiatric Disease and Treatment, 2013 Cesario Bellantuono, Francesca Bozzi, Laura Orsolini Psychiatric Unit and DEGRA Center, United Hospital and Academic Department of Experimental and Clinical Medicine, Polytechnic University of Marche, Ancona, Italy Background: The aim of this paper is to
Bellantuono C, Bozzi F, Orsolini L
doaj +2 more sources
Review: Escitalopram—translating molecular properties into clinical benefit: reviewing the evidence in major depression [PDF]
, 2010 The majority of currently marketed drugs contain a mixture of enantiomers; however, recent evidence suggests that individual enantiomers can have pharmacological properties that differ importantly from enantiomer mixtures.
Taylor, David +2 more
core +1 more source
Neuromodulation: Technology at the Neural Interface, EarlyView., 2021 Abstract Objectives Obsessive–compulsive disorder (OCD) is a psychiatric disorder with alterations of cortico‐striato‐thalamo‐cortical loops and impaired performance monitoring. Electrophysiological markers such as conflict‐related medial frontal theta (MFT) and error‐related negativity (ERN) may be altered by clinically effective deep brain ...
Elena Sildatke +9 more
wiley +1 more source